AlphaMadera's AlphaVal page classifies Markel Corporation as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag MKL as undervalued, fairly valued, or overvalued.

What is Markel Corporation's fair value?

Fair value for MKL comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value MKL?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. MKL was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from MKL's most recent reported fundamentals.

MKL - Markel Corporation

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $1,950.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong

Trading 44.3% below fair value

Current Price $1826.72

Bear Case $2,181.43 19.4% upside ($2,181.43 - $1,826.72) / $1,826.72 = 19.4% ROTCE 11.9% → 2.03x TBV

Fair Value $3,278.57 79.5% upside ($3,278.57 - $1,826.72) / $1,826.72 = 79.5% ROTCE 15.8% → 3.05x TBV

Bull Case $3,936.86 115.5% upside ($3,936.86 - $1,826.72) / $1,826.72 = 115.5% ROTCE 18.2% → 3.66x TBV

Adjust Assumptions

Return on Tangible Equity

15.8%

Cost of Equity

7.9%

Key Value Driver

ROTCE (15.8%) vs. cost of equity (7.9%)

Terminal Value % of EV

Implied Market Multiple 1.7x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 15.8% vs. 7.9% cost of equity, fair P/TBV is 3.05x on $1075.31 tangible book, implying $3278.57 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (15 analysts) $1950.00

Analyst Range $1950.00 – $1950.00

Divergence from AlphaVal 68%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Wall Street's average price target is $1950.00 (from 15 analysts). Our estimate is 68% above the consensus -- consider that gap carefully.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly